Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods

Details for Australian Patent Application No. 2001274947 (hide)

Owner CeNeS Pharmaceuticals, Inc.

Inventors Marchionni, Mark A

Agent Callinan

Pub. Number AU-B-2001274947

PCT Pub. Number WO01/89568

Priority 60/206,495 23.05.00 US

Filing date 23 May 2001

Wipo publication date 3 December 2001

Acceptance publication date 17 August 2006

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

Event Publications

17 August 2006 Application Accepted

  Published as AU-B-2001274947

14 December 2006 Standard Patent Sealed

19 April 2007 Assignment Registered

  CeNes Pharmacueticals, Inc. The patent has been assigned to Acorda Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001274948

2001274946